Photo: latimes.com
Sep 2, 2025, 06:39
Pat Soon-Shiong: NK and T Cell Activation Shows Promise in Advanced Lung Cancer
Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, Executive Chairman of Los Angeles Times, shared a post on X:
“NCI supported PRAGMATICA lung trial failed but established real world survival after chemo of 9 months. Our Bioshield trial in lung patients who progressed show when NK and T cells are activated, survival is doubled and some patients live 4+ years in late stage of cancer.
Coming this week.”
More posts featuring Pat Soon-Shiong.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 16:27
Sep 2, 2025, 16:24
Sep 2, 2025, 16:18
Sep 2, 2025, 15:56
Sep 2, 2025, 15:45